PT - JOURNAL ARTICLE AU - Gautam Kumar Baboo AU - Raghav Prasad AU - Pranav Mahajan AU - Veeky Baths TI - Tracking the Progression & Influence of Beta-Amyloid Plaques Using Percolation Centrality and Collective Influence Algorithm: A Study using PET images AID - 10.1101/2020.10.12.20211607 DP - 2021 Jan 01 TA - medRxiv PG - 2020.10.12.20211607 4099 - http://medrxiv.org/content/early/2021/01/24/2020.10.12.20211607.short 4100 - http://medrxiv.org/content/early/2021/01/24/2020.10.12.20211607.full AB - Network analysis allows investigators to explore the many facets of brain networks, particularly the proliferation of disease, using graph theory to model the disease movement. One of the hypotheses behind the disruption in brain networks in Alzheimer’s disease (AD) is the abnormal accumulation of beta-amyloid plaques and tau protein tangles. In this study, the potential use of percolation centrality to study the movement of beta-amyloids, as a feature of given PET image-based networks, is studied. The PET image-based network construction is possible using a public access database - Alzheimer’s Disease Neuroimaging Initiative, which provided 551 scans. For each image, the Julich atlas provides 121 regions of interest, which are the network nodes. Besides, the influential nodes for each scan are calculated using the collective influence algorithm. Analysis of variance (p<0.05) yields the region of interest GM Superior parietal lobule 7A L, for which percolation centrality is significant irrespective of the tracer type. Pairwise variance analysis between the clinical groups provides five and twelve candidates for AV45 and PiB. Multivariate linear regression between the percolation centrality values for nodes and psychometric assessment scores reveals Mini-Mental State Examination is a reliable metric. Finally, a ranking of the regions of interest is made based on the collective influence algorithm to indicate the anatomical areas strongly influencing the beta-amyloid network. Through this study, it is possible to use percolation centrality values to indicate the regions of interest that reflect the disease’s spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementData usage and analysis for this study is enabled by the Alzheimer's Disease Neuroimaging Initiative - National Institutes of Health Grant U01 AG024904, DOD ADNI, Department of Defense award number W81XWH-12-2-0012Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Informed consent from the patients is obtained prior to the assessment carried out by ADNI study team (See ADNI website for details), and this study is a secondary data analysis of the ADNI data collection, which aims at providing a simplified metric to an already diagnosed patient.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPET image data is obtained from the Alzheimer's Disease Neuroimaging Initiative. All processed data will be provided on request. http://adni.loni.usc.edu ADAlzheimer’s DiseaseANOVAAnalysis of VarianceAV45Florbetapir (18F-AV-45)CICollective InfluenceCNCognitively NormalCSFCerebrospinal FluidEEGElectroencephalographyFABFrontal Assessment BatteryFDGFluorodeoxyglucose (18F-FDG)fMRIfunctional Magnetic Resonance ImagingFSLFMRIB Software LibraryGNUGNU’s Not UnixPCvPercolation Centrality Value PET, Positron Emission tomographyPiBPittsburgh compound B (11C-PIB)RMSERoot Mean Square ErrorMCIMild Cognitive ImpairmentMEGMagnetoencephalographyMLRMultivariate Linear RegressionMMSEMini-Mental State ExaminationNPIQNeuropsychiatric Inventory QuestionnaireOMSTOrthogonal Minimum Spanning Tree